|
US2014162881A1
|
|
Use of ribose to enhance plant growth
|
|
WO2010096689A1
|
|
Compositions and methods for feeding poultry
|
|
AU2009283215A1
|
|
Use of D-ribose for fatigued subjects
|
|
CA2735949A1
|
|
Use of ribose in lessening the clinical symptoms of aberrant firing of neurons
|
|
CN106138071A
|
|
Ribose is for the purposes in the first reaction of acute myocardial infarction
|
|
EP2120968A1
|
|
Use of d-ribose to treat atrial fibrillations
|
|
BRPI0718356A2
|
|
'' method for treating subideal lung function ''
|
|
WO2006065881A2
|
|
Use of ribose to alleviate rhabdomyolysis and the side effects of statin drugs
|
|
WO2005067548A2
|
|
Use of ribose in recovery from anaesthesia
|
|
US7553817B2
|
|
Methods for improving cardiac function
|
|
AU2003272198A1
|
|
Storage of blood
|
|
WO02078446A1
|
|
Composition to reduce exercise-induced swelling of joints
|
|
CN1454090A
|
|
Compositions and methods for improving cardiovascular function
|
|
EP1247525A1
|
|
Use of a monosaccharide in the manufacture of a medicament against acute mountain sickness
|
|
US6511964B2
|
|
Method for treating acute mountain sickness
|
|
US6525027B2
|
|
Use of ribose supplementation for increasing muscle mass and decreasing body fat in humans
|
|
WO0151062A1
|
|
Compositions for enhancing the immune response
|
|
WO0145502A1
|
|
Compositions for the storage of platelets
|
|
US6534480B2
|
|
Compositions for increasing energy in vivo
|
|
EP1095658A2
|
|
Use of ribose to treat fibromyalgia
|
